4//SEC Filing
McLaughlin Gerald W. 4
Accession 0001104659-18-042932
CIK 0001467652other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 6:06 PM ET
Size
5.3 KB
Accession
0001104659-18-042932
Insider Transaction Report
Form 4
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-06-27+600,000→ 600,000 totalExercise: $6.20Exp: 2028-06-27→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]This stock option was granted pursuant to the Company's 2018 Inducement Plan and vests in equal annual installments over a four-year period which began on June 27, 2018.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeother
Related Parties
1- filerCIK 0001495412
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 6:06 PM ET
- Size
- 5.3 KB